Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Berry

Showing results (81-90 of 176) with videos related to

Pageof 18
Sort By:
Muscle & Nerve|October 29, 2020
Smartphone data during the COVID-19 pandemic can quantify behavioral changes in people with ALSAnna L Beukenhorst, Ella Collins, Katherine M Burke, et al.
JMIR Mhealth and Uhealth|February 4, 2022
Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational StudiesAnna L Beukenhorst, Katherine M Burke, Zoe Scheier, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 22, 2023
Resilient together-ALS: leveraging the NDD transdiagnostic framework to develop an early dyadic intervention for people with amyotrophic lateral sclerosis and their informal care-partnersChristina L Rush, Ethan G Lester, Heena Manglani, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
Journal of Pain and Symptom Management|December 20, 2024
Clinician Perspectives Highlight the Need for Early Dyadic Coping Skills for People Living With Amyotrophic Lateral SclerosisChristina L Rush, Chris Lyons, Jenna Gittle, et al.
Journal of Neurology|March 4, 2020
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosisFabiola De Marchi, James D Berry, James Chan, et al.
BMC Neurology|May 31, 2019
Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALSAnne Marie Wills, Jamie Garry, Jane Hubbard, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 26, 2011
Biochemical alterations associated with ALSKay A Lawton, Merit E Cudkowicz, Meredith V Brown, et al.
American Journal of Speech-Language Pathology|June 3, 2025
Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index-RemoteTimothy Pommée, Liziane Bouvier, Carolina Barnett-Tapia, et al.
Neuroscience and Biobehavioral Reviews|June 21, 2021
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impactFabiola De Marchi, Ivana Munitic, Amedeo Amedei, et al.
Pageof 18

Showing results (81-90 of 176) with videos related to

Sort By:
Pageof 18
Muscle & Nerve|October 29, 2020
Smartphone data during the COVID-19 pandemic can quantify behavioral changes in people with ALSAnna L Beukenhorst, Ella Collins, Katherine M Burke, et al.
JMIR Mhealth and Uhealth|February 4, 2022
Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational StudiesAnna L Beukenhorst, Katherine M Burke, Zoe Scheier, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 22, 2023
Resilient together-ALS: leveraging the NDD transdiagnostic framework to develop an early dyadic intervention for people with amyotrophic lateral sclerosis and their informal care-partnersChristina L Rush, Ethan G Lester, Heena Manglani, et al.
JAMA Neurology|October 17, 2022
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A ReviewJeremy M Shefner, Richard Bedlack, Jinsy A Andrews, et al.
Journal of Pain and Symptom Management|December 20, 2024
Clinician Perspectives Highlight the Need for Early Dyadic Coping Skills for People Living With Amyotrophic Lateral SclerosisChristina L Rush, Chris Lyons, Jenna Gittle, et al.
Journal of Neurology|March 4, 2020
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosisFabiola De Marchi, James D Berry, James Chan, et al.
BMC Neurology|May 31, 2019
Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALSAnne Marie Wills, Jamie Garry, Jane Hubbard, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 26, 2011
Biochemical alterations associated with ALSKay A Lawton, Merit E Cudkowicz, Meredith V Brown, et al.
American Journal of Speech-Language Pathology|June 3, 2025
Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index-RemoteTimothy Pommée, Liziane Bouvier, Carolina Barnett-Tapia, et al.
Neuroscience and Biobehavioral Reviews|June 21, 2021
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impactFabiola De Marchi, Ivana Munitic, Amedeo Amedei, et al.
Pageof 18